<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39464376</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2090-1844</ISSN><JournalIssue CitedMedium="Internet"><Volume>2024</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Pulmonary medicine</Title><ISOAbbreviation>Pulm Med</ISOAbbreviation></Journal><ArticleTitle>The Impact of COVID-19 Pandemic on Respiratory Syncytial Virus Infection in Children.</ArticleTitle><Pagination><StartPage>2131098</StartPage><MedlinePgn>2131098</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2131098</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2024/2131098</ELocationID><Abstract><AbstractText><b>Background/Objective:</b> Respiratory syncytial virus (RSV) is a major cause of bronchiolitis in infants and young children. Bronchiolitis, an acute inflammation of the lower respiratory tract, can lead to pneumonia, respiratory failure, and death. We aimed to compare the incidence and severity of RSV infection in children aged 0-60 months before and during the coronavirus disease 2019 (COVID-19) pandemic. <b>Methods:</b> A retrospective chart review was conducted on patients aged 0-60 months who tested positive for RSV between May 1, 2018, and May 31, 2022, in a community hospital in Queens County, New York City, United States. Comparisons were made between seasons 2018-2019 and 2019-2020 as before, and seasons 2020-2021 and 2021-2022 as during the COVID-19 pandemic. Severity of RSV infection was assessed using the Bronchiolitis Severity Score (BSS). Data were analyzed using R software, a <i>p</i> value of &lt; 0.05 was considered statistically significant. <b>Results:</b> The incidence of RSV infection in seasons 2018-2019 and 2019-2020 peaked from mid-October to February, whereas the first season during the COVID-19 pandemic (2020-2021) was truncated with a very low incidence of RSV infection, and season 2021-2022 peaked from September to January, with the highest incidence (37%) and lower frequency of RSV infection at any given point. Patients during the season 2021-2022 were older (<i>H</i> [2, 196.6] = 12.5, <i>p</i> &lt; 0.001, 95% <i>CI</i> = [5.4, 25.6]) and had milder illness (<i>H</i> [2, 187.5] = 7.5, <i>p</i> &lt; 0.01, 95% <i>CI</i> = [2.1, 19.2]). <b>Conclusions:</b> We observed a lower incidence of RSV infection and a lower rate of hospitalization for RSV during the COVID-19 pandemic. The second RSV season during the COVID-19 pandemic began earlier, lasted longer, and had a lower frequency. Older children with milder illnesses were affected most during this season. RSV epidemiology and disease burden were impacted by the COVID-19 pandemic and could have significant ramifications for its prevention and control strategies.</AbstractText><CopyrightInformation>Copyright © 2024 Jose Boris Trigueros Montes et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trigueros Montes</LastName><ForeName>Jose Boris</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Flushing Hospital Medical Center, Flushing, New York 11355, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montes</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biology, Baylor University, Waco, Texas 76706, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miele</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1384-657X</Identifier><AffiliationInfo><Affiliation>Department of Research Education and Innovation, Medisys Health Network, Jamaica, New York 11418, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baik-Han</LastName><ForeName>Won</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Flushing Hospital Medical Center, Flushing, New York 11355, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulati</LastName><ForeName>Gagan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Flushing Hospital Medical Center, Flushing, New York 11355, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lew</LastName><ForeName>Lily Q</ForeName><Initials>LQ</Initials><Identifier Source="ORCID">0000-0001-6926-2883</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Flushing Hospital Medical Center, Flushing, New York 11355, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>Pulm Med</MedlineTA><NlmUniqueID>101558762</NlmUniqueID><ISSNLinking>2090-1844</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39464376</ArticleId><ArticleId IdType="pmc">PMC11511594</ArticleId><ArticleId IdType="doi">10.1155/2024/2131098</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Piedimonte G., Perez M. K. Respiratory syncytial virus infection and bronchiolitis. Pediatrics in Review . 2014;35(12):519–530. doi: 10.1542/pir.35.12.519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.35.12.519</ArticleId><ArticleId IdType="pmc">PMC5029757</ArticleId><ArticleId IdType="pubmed">25452661</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose E. B., Wheatley A., Langley G., Gerber S., Haynes A. Respiratory syncytial virus seasonality-United States, 2014-2017. MMWR. Morbidity and Mortality Weekly Report . 2018;67(2):71–76. doi: 10.15585/mmwr.mm6702a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6702a4</ArticleId><ArticleId IdType="pmc">PMC5772804</ArticleId><ArticleId IdType="pubmed">29346336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamid S., Winn A., Parikh R., et al. Seasonality of respiratory syncytial virus-United States, 2017-2023. MMWR. Morbidity and Mortality Weekly Report . 2023;72(14):355–361. doi: 10.15585/mmwr.mm7214a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7214a1</ArticleId><ArticleId IdType="pmc">PMC10078848</ArticleId><ArticleId IdType="pubmed">37022977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaler J., Hussain A., Patel K., Hernandez T., Ray S. Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Cureus . 2023;15(3, article e36342) doi: 10.7759/cureus.36342.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36342</ArticleId><ArticleId IdType="pmc">PMC10111061</ArticleId><ArticleId IdType="pubmed">37082497</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Raya B., Viñeta Paramo M., Reicherz F., Lavoie P. M. Why has the epidemiology of RSV changed during the COVID-19 pandemic? EClinicalMedicine . 2023;61, article 102089 doi: 10.1016/j.eclinm.2023.102089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102089</ArticleId><ArticleId IdType="pmc">PMC10359735</ArticleId><ArticleId IdType="pubmed">37483545</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin H. J., Seng Q. B. Reliability and validity of the respiratory score in the assessment of acute bronchiolitis. Malaysian Journal of Medical Sciences . 2004;11(2):34–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3433974</ArticleId><ArticleId IdType="pubmed">22973125</ArticleId></ArticleIdList></Reference><Reference><Citation>“New York City, U.S. Epicenter, Braces for Peak” NPR March 24, 2020.  COVID-19 pandemic in New York City,  https://en.wikipedia.org/w/index.php?title=COVID-19_pandemic_in_New_York_City%26oldid=1198106018.</Citation></Reference><Reference><Citation>Fedorczak A., Zielińska N., Nosek-Wasilewska P., et al. Comparison of COVID-19 and RSV infection courses in infants and children under 36 months hospitalized in paediatric department in fall and winter season 2021/2022. Journal of Clinical Medicine . 2022;11(23):p. 7088. doi: 10.3390/jcm11237088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11237088</ArticleId><ArticleId IdType="pmc">PMC9741168</ArticleId><ArticleId IdType="pubmed">36498663</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini R., Gilca R., Boucher F. D., Charest H., De Serres G. Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children &lt;2 years during seasonal influenza peaks. Infection . 2019;47(4):595–601. doi: 10.1007/s15010-019-01287-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-019-01287-5</ArticleId><ArticleId IdType="pmc">PMC7100292</ArticleId><ArticleId IdType="pubmed">30798473</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley C. M., Haynes A. K., Baumgardner J. L., et al. Determining the seasonality of respiratory syncytial virus in the United States: the impact of increased molecular testing. The Journal of Infectious Diseases . 2017;216(3):345–355. doi: 10.1093/infdis/jix275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix275</ArticleId><ArticleId IdType="pmc">PMC5712458</ArticleId><ArticleId IdType="pubmed">28859428</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein R. T., Zar H. J. RSV through the COVID-19 pandemic: burden, shifting epidemiology, and implications for the future. Pediatric Pulmonology . 2023;58(6):1631–1639. doi: 10.1002/ppul.26370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26370</ArticleId><ArticleId IdType="pubmed">36811330</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels D., Wang D., Suryadevara M., et al. Epidemiology of RSV bronchiolitis among young children in Central New York before and after the onset of the COVID-19 pandemic. The Pediatric Infectious Disease Journal . 2023;42(12):1056–1062. doi: 10.1097/INF.0000000000004101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000004101</ArticleId><ArticleId IdType="pubmed">37725814</ArticleId></ArticleIdList></Reference><Reference><Citation>Viñeta Paramo M., Ngo L. P. L., Abu-Raya B., et al. Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study. The Lancet Regional Health . 2023;25, article 100582 doi: 10.1016/j.lana.2023.100582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2023.100582</ArticleId><ArticleId IdType="pmc">PMC10495630</ArticleId><ArticleId IdType="pubmed">37705884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdeau M., Vadlamudi N. K., Bastien N., et al. Pediatric RSV-associated hospitalizations before and during the COVID-19 pandemic. JAMA Network Open . 2023;6(10, article e2336863) doi: 10.1001/jamanetworkopen.2023.36863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.36863</ArticleId><ArticleId IdType="pmc">PMC10551765</ArticleId><ArticleId IdType="pubmed">37792376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatoun J., Correa E. T., Vernacchio L. COVID-19 pandemic-related changes in pediatric seasonal respiratory infections. Pediatrics . 2022;150(4, article e2022058618) doi: 10.1542/peds.2022-058618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-058618</ArticleId><ArticleId IdType="pubmed">35918801</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha R., Avner J. R. Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics . 2021;148(3, article e2021052089) doi: 10.1542/peds.2021-052089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-052089</ArticleId><ArticleId IdType="pubmed">34108234</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Davis P. B., Berger N., Kaelber D. C., Volkow N., Xu R. Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0-5 years in the USA in 2022: a multicentre retrospective cohort study. Family Medicine and Community Health . 2023;11(4, article e002456) doi: 10.1136/fmch-2023-002456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fmch-2023-002456</ArticleId><ArticleId IdType="pmc">PMC10582888</ArticleId><ArticleId IdType="pubmed">37832975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Armistead I., Messacar K., et al. Shifting epidemiology and severity of respiratory syncytial virus in children during the COVID-19 pandemic. JAMA Pediatrics . 2023;177(7):730–732. doi: 10.1001/jamapediatrics.2023.1088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.1088</ArticleId><ArticleId IdType="pmc">PMC10186203</ArticleId><ArticleId IdType="pubmed">37184852</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley D. A., Phuong L. K., Peplinski J., et al. Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia. Archives of Disease in Childhood . 2022;107(3):e1.2–e1e7. doi: 10.1136/archdischild-2021-322507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-322507</ArticleId><ArticleId IdType="pubmed">34433552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ujiie M., Tsuzuki S., Nakamoto T., Iwamoto N. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerging Infectious Diseases . 2021;27(11):2969–2970. doi: 10.3201/eid2711.211565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2711.211565</ArticleId><ArticleId IdType="pmc">PMC8544984</ArticleId><ArticleId IdType="pubmed">34388086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardsley M., Morbey R. A., Hughes H. E., et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. The Lancet Infectious Diseases . 2023;23(1):56–66. doi: 10.1016/S1473-3099(22)00525-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00525-4</ArticleId><ArticleId IdType="pmc">PMC9762748</ArticleId><ArticleId IdType="pubmed">36063828</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado S. New climate projections: NYC will keep getting hotter and wetter.  The City 2024  https://www/thecity.nyc/author/samantha-maldonado.</Citation></Reference><Reference><Citation>Baker R. E., Mahmud A. S., Wagner C. E., et al. Epidemic dynamics of respiratory syncytial virus in current and future climates. Nature Communications . 2019;10(1):p. 5512. doi: 10.1038/s41467-019-13562-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13562-y</ArticleId><ArticleId IdType="pmc">PMC6892805</ArticleId><ArticleId IdType="pubmed">31797866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P. I., Liu C. C., Hu Y. L., Chen J. M. Seasonality and risk factor analysis of respiratory syncytial virus infection in children in Taiwan-a retrospective study from 1995 to 2005. Journal of Medical Virology . 2023;95(10, article e29116) doi: 10.1002/jmv.29116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29116</ArticleId><ArticleId IdType="pubmed">37772669</ArticleId></ArticleIdList></Reference><Reference><Citation>Verwey C., Madhi S. A. Review and update of active and passive immunization against respiratory syncytial virus. BioDrugs . 2023;37(3):295–309. doi: 10.1007/s40259-023-00596-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40259-023-00596-4</ArticleId><ArticleId IdType="pmc">PMC10127166</ArticleId><ArticleId IdType="pubmed">37097594</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M., Kubale J., Kuan G., et al. Respiratory syncytial virus incidence and severity in a community-based prospective cohort of children aged 0-14 years. Open Forum Infectious Diseases . 2022;9(11, article ofac598) doi: 10.1093/ofid/ofac598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac598</ArticleId><ArticleId IdType="pmc">PMC9697591</ArticleId><ArticleId IdType="pubmed">36447616</ArticleId></ArticleIdList></Reference><Reference><Citation>Laham F. R., Mansbach J. M., Piedra P. A., et al. Clinical profiles of respiratory syncytial virus subtypes A and B among children hospitalized with bronchiolitis. The Pediatric Infectious Disease Journal . 2017;36(8):808–810. doi: 10.1097/INF.0000000000001596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001596</ArticleId><ArticleId IdType="pmc">PMC5556381</ArticleId><ArticleId IdType="pubmed">28383391</ArticleId></ArticleIdList></Reference><Reference><Citation>Caserta M. T., O’Leary S. T., Munoz F. M., Ralston S. L. Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics . 2023;152(1, article e2023061803) doi: 10.1542/peds.2023-061803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-061803</ArticleId><ArticleId IdType="pubmed">37357729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J. M., Fleming-Dutra K. E., Prill M. M., et al. Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the advisory committee on immunization practices-United States, 2023. MMWR. Morbidity and Mortality Weekly Report . 2023;72(34):920–925. doi: 10.15585/mmwr.mm7234a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7234a4</ArticleId><ArticleId IdType="pmc">PMC10468217</ArticleId><ArticleId IdType="pubmed">37616235</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E. FDA approves maternal RSV vaccine. JAMA . 2023;330(11, article 1029) doi: 10.1001/jama.2023.16106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.16106</ArticleId><ArticleId IdType="pubmed">37647088</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X. L., Zhang X., Hua W., et al. Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children. World Journal of Pediatrics . 2024;20(1):11–25. doi: 10.1007/s12519-023-00777-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00777-9</ArticleId><ArticleId IdType="pmc">PMC10828005</ArticleId><ArticleId IdType="pubmed">38064012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong B., Koç U., Bandeira T., et al. Changes in the global hospitalization burden of respiratory syncytial virus in young children during COVID-19 pandemic: a systematic analysis. The Lancet Infectious Diseases . 2024;24(4):361–374. doi: 10.1016/S1473-3099(23)00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00630-8</ArticleId><ArticleId IdType="pmc">PMC11290460</ArticleId><ArticleId IdType="pubmed">38141633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>